97 related articles for article (PubMed ID: 21239889)
1. Transforming blood vessels into bone.
Medici D; Olsen BR
Cell Cycle; 2011 Feb; 10(3):362-3. PubMed ID: 21239889
[No Abstract] [Full Text] [Related]
2. Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva.
Chakkalakal SA; Shore EM
Methods Mol Biol; 2019; 1891():247-255. PubMed ID: 30414138
[TBL] [Abstract][Full Text] [Related]
3. Identification of the Identical Human Mutation in
Casal ML; Engiles JB; Zakošek Pipan M; Berkowitz A; Porat-Mosenco Y; Mai W; Wurzburg K; Xu MQ; Allen R; ODonnell PA; Henthorn PS; Thompson K; Shore EM
Vet Pathol; 2019 Jul; 56(4):614-618. PubMed ID: 31007133
[TBL] [Abstract][Full Text] [Related]
4. Fibrodysplasia ossificans progressiva.
Ganguly S; Paul DK; Ghosal B; Choube A
Indian J Pediatr; 1994; 61(4):417-21. PubMed ID: 8002073
[No Abstract] [Full Text] [Related]
5. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular characterisation of two siblings with fibrodysplasia ossificans progressiva, from the Colombian Pacific coast (South America).
Pachajoa H; Botero AF
BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26055602
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
Kaplan FS; Glaser DL; Shore EM; Pignolo RJ; Xu M; Zhang Y; Senitzer D; Forman SJ; Emerson SG
J Bone Joint Surg Am; 2007 Feb; 89(2):347-57. PubMed ID: 17272450
[TBL] [Abstract][Full Text] [Related]
8. An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
Hino K; Zhao C; Horigome K; Nishio M; Okanishi Y; Nagata S; Komura S; Yamada Y; Toguchida J; Ohta A; Ikeya M
Stem Cell Reports; 2018 Nov; 11(5):1106-1119. PubMed ID: 30392977
[TBL] [Abstract][Full Text] [Related]
9. Role of osteoclasts in heterotopic ossification enhanced by fibrodysplasia ossificans progressiva-related activin-like kinase 2 mutation in mice.
Kawao N; Yano M; Tamura Y; Okumoto K; Okada K; Kaji H
J Bone Miner Metab; 2016 Sep; 34(5):517-25. PubMed ID: 26204847
[TBL] [Abstract][Full Text] [Related]
10. Heterotopic mesenteric ossification of ileostomy - "intraabdominal myositis ossificans".
Sapalidis K; Strati TM; Liavas L; Kotidis E; Koletsa T; Tsiompanou F; Kanellos I; Albu DF
Rom J Morphol Embryol; 2016; 57(1):277-81. PubMed ID: 27151721
[TBL] [Abstract][Full Text] [Related]
11. [Facial circumscribed ossifying myositis. Anatomo-clinical and tomodensitometric study].
Chomette G; Goudot P; Auriol M; Vidal JM; Tranbaloc P; Wechsler B; Vaillant JM; Guilbert F
Rev Stomatol Chir Maxillofac; 1989; 90(1):1-6. PubMed ID: 2497507
[TBL] [Abstract][Full Text] [Related]
12. Ectopic ossification.
Kewalramani LS
Am J Phys Med; 1977 Jun; 56(3):99-121. PubMed ID: 405873
[TBL] [Abstract][Full Text] [Related]
13. The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent.
Upadhyay J; Xie L; Huang L; Das N; Stewart RC; Lyon MC; Palmer K; Rajamani S; Graul C; Lobo M; Wellman TJ; Soares EJ; Silva MD; Hesterman J; Wang L; Wen X; Qian X; Nannuru K; Idone V; Murphy AJ; Economides AN; Hatsell SJ
J Bone Miner Res; 2017 Dec; 32(12):2489-2499. PubMed ID: 28782882
[TBL] [Abstract][Full Text] [Related]
14. Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP).
Kaplan FS; Shen Q; Lounev V; Seemann P; Groppe J; Katagiri T; Pignolo RJ; Shore EM
J Bone Miner Metab; 2008; 26(6):521-30. PubMed ID: 18979151
[TBL] [Abstract][Full Text] [Related]
15. Deregulated bone morphogenetic protein receptor signaling underlies fibrodysplasia ossificans progressiva.
de Gorter DJ; Jankipersadsing V; Ten Dijke P
Curr Pharm Des; 2012; 18(27):4087-92. PubMed ID: 22630080
[TBL] [Abstract][Full Text] [Related]
16. Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva.
Ravazzolo R; Cappato S; Bocciardi R
Bone; 2018 Apr; 109():187-191. PubMed ID: 29100956
[TBL] [Abstract][Full Text] [Related]
17. Differential Vascularity in Genetic and Nonhereditary Heterotopic Ossification.
Ware AD; Brewer N; Meyers C; Morris C; McCarthy E; Shore EM; James AW
Int J Surg Pathol; 2019 Dec; 27(8):859-867. PubMed ID: 31250694
[No Abstract] [Full Text] [Related]
18. [Post-traumatic ossification of the soft tissue].
Witwicki T; Daniluk A; Dulowski W; Górecki A
Chir Narzadow Ruchu Ortop Pol; 1978; 43(1):29-32. PubMed ID: 417909
[No Abstract] [Full Text] [Related]
19. Myositis ossificans-like lesion of nerve.
Wasman JK; Willis J; Makley J; Abdul-Karim FW
Histopathology; 1997 Jan; 30(1):75-8. PubMed ID: 9023561
[TBL] [Abstract][Full Text] [Related]
20. Heterotopic mesenteric ossification ('intraabdominal myositis ossificans'): report of five cases.
Wilson JD; Montague CJ; Salcuni P; Bordi C; Rosai J
Am J Surg Pathol; 1999 Dec; 23(12):1464-70. PubMed ID: 10584699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
